Search Results
Silence Therapeutics hits first milestone in Mallinckrodt deal
Silence Therapeutics hails 'transformational' deal with US firm Mallinckrodt
Executive interview – Silence Therapeutics
Silence Therapeutics CEO talks recent RNAi deals and updates on critical SLN124 trial
Silence Therapeutics 'charging ahead with its key programmes' as it looks to do more deals
Silence Therapeutics (SLN) - Dr. Rob Quinn, Interim CFO
Silence Therapeutics (SLN) - Dr. Rob Quinn, CFO
Silence Therapeutics - Proactive Webinar Event March 26th 2020
Silence Therapeutics (SLN) - Dr. Rob Quinn, CFO
Silence Therapeutics - Proactive One2One Virtual Event
New GalNAc delivery technology 'a game-changer' says Silence Therapeutics chief
SILENCE THERAPEUTICS PLC Company Profile and Tech Intelligence Report, 2018
